2026年全球藥物與基因遞送設備市場報告

近年來，藥物和基因遞送裝置的市場規模經歷了顯著成長，預計將從2025年的6.7億美元成長到2026年的7.3億美元，複合年成長率為8.9%。過去幾年的成長可歸因於先進遞送裝置的供不應求、對傳統給藥途徑的依賴、早期基因療法的開發、生物製藥產品線的擴展以及對研究合作投入的增加。

預計未來幾年，藥物和基因遞送裝置市場將保持強勁成長，到2030年市場規模將達到10.1億美元，複合年成長率（CAGR）為8.6%。預測期內的成長要素包括病毒和非病毒載體技術的進步、個人化醫療和基因治療應用範圍的擴大、創新遞送系統監管核准的增加、奈米藥物和脂質奈米顆粒（LNP）的日益普及，以及數位監測和智慧遞送平台的整合。預測期內的主要趨勢包括標靶藥物和基因治療的成長、基於奈米顆粒的遞送系統應用的增加、病毒載體在基因治療中的應用日益廣泛、注射和非侵入性遞送方法的擴展，以及對個性化醫療和緩釋技術的關注。

基因療法的日益普及預計將推動藥物和基因遞送裝置市場的未來成長。基因療法是一種透過修改患者細胞中的遺傳物質來治療或預防疾病的方法，因其有望解決遺傳性和慢性疾病的根本原因而備受關注。基因療法的廣泛應用正在推動對先進遞送系統的需求，這些系統能夠實現治療基因的精準標靶化和可控釋放。藥物和基因遞送裝置在提高治療效果和安全性方面發揮著至關重要的作用。例如，根據美國非營利組織美國基因與細胞治療學會（ASCG​​TC）的數據顯示，截至2025年1月，2024年第四季的基因治療計畫預註冊數量較第三季度增加了83%。因此，基因療法的日益普及正在推動整個藥物和基因遞送裝置市場的成長。

為了提升市場競爭力，製藥和基因遞送設備市場的主要企業正致力於開發先進解決方案，例如基於人工智慧（AI）的技術。人工智慧技術在藥物傳遞領域的應用旨在透過應用先進的演算法和數據驅動模型，提高遞送的準確性、效率和治療效果。例如，2023年12月，總部位於美國的聚合物奈米顆粒開發商Emboya宣布推出一項創新的基因治療遞送平台，將生物聚合物奈米顆粒與人工智慧結合。該平台旨在解決現有基因遞送方法面臨的挑戰，例如病毒載體和脂質奈米顆粒相關的安全問題、有效載荷能力有限以及組織標靶化不足等。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球藥物及基因遞送設備市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 人工智慧（AI）和自主人工智慧
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 標靶藥物和基因治療的發展
  • 奈米顆粒遞送系統的應用日益廣泛
  • 基因治療中病毒載體的應用日益廣泛
  • 拓展注射式和非侵入性給藥方式
  • 專注於個人化醫療和緩釋技術

第5章 終端用戶產業市場分析

• 製藥公司
• 生技公司
• 醫院和診所
• 研究所
• 合約研究與製造組織（CRAMOS）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球藥物和基因遞送設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球藥物和基因遞送設備市場規模、對比及成長率分析
• 全球藥物和基因遞送設備市場表現：規模和成長，2020-2025年
• 全球藥物和基因遞送設備市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 向量
• 病毒性和非病毒性
• 透過方法
• 原位，離體
• 透過行政途徑
• 口服、吸入、經皮、注射、眼用、鼻用、局部用藥
• 按類型細分：病毒
• 腺病毒載體、慢病毒載體、腺結合病毒（AAV）載體、單純皰疹病毒（HSV）載體、逆轉錄病毒載體、桿狀病毒載體、痘苗病毒載體、仙台病毒載體
• 按類型細分：非病毒性
• 脂質奈米顆粒（LNP）、聚合物奈米顆粒、脂質體、樹狀聚合物、裸露DNA/RNA遞送、基於電穿孔的遞送系統、基於奈米顆粒的遞送系統、高分子奈米微胞和水凝膠

第10章 區域與國家分析

• 全球藥物與基因傳遞設備市場：區域分析、預測與成長，2020-2025年、2025-2030年預測、2035年預測
• 全球藥物和基因遞送設備市場：按國家/地區分類，實際值和預測值，2020-2025年、2025-2030年預測值、2035年預測值

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 藥物和基因遞送設備市場：競爭格局和市場佔有率，2024 年
• 藥物與基因遞送設備市場：公司估值矩陣
• 藥物和基因遞送設備市場：公司概況
  • Medtronic plc
  • Moderna Inc.
  • Halozyme Therapeutics Inc.
  • Uniqure NV
  • Intellia Therapeutics Inc.

第37章：其他領先和創新企業

• Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics SA, CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年藥物和基因遞送設備市場：提供新機會的國家
• 2030年藥物與基因傳遞設備市場：充滿新機會的細分市場
• 2030年藥物與基因遞送設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Drug and gene delivery devices are technologies designed to transport medications or genetic material into the body for targeted therapy. They enable precise delivery to specific tissues or cells, reducing side effects and improving treatment effectiveness.

The key vector categories of drug and gene delivery devices include viral and non-viral vectors. Viral gene delivery uses genetically modified viruses to transport therapeutic genes into target cells. The delivery methods include in situ and ex vivo techniques, and the routes of administration include oral, inhalation, transdermal, injectable, ocular, nasal, and topical routes.

Tariffs are impacting the drug and gene delivery devices market by increasing the cost of imported materials, components, and specialized manufacturing equipment for viral and non-viral vector production. Segments such as lipid nanoparticles, polymeric nanoparticles, and viral vectors are most impacted, particularly in regions like North America and Asia-Pacific. While tariffs have raised production costs and slowed supply chains, they have also encouraged local manufacturing, investment in domestic capabilities, and innovation in alternative materials and delivery technologies.

The drug and gene delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug and gene delivery devices market statistics, including drug and gene delivery devices industry global market size, regional shares, competitors with a drug and gene delivery devices market share, detailed drug and gene delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug and gene delivery devices industry. This drug and gene delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.67 billion in 2025 to $0.73 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to limited availability of advanced delivery devices, reliance on conventional administration routes, early-stage gene therapy development, growing biologics pipeline, increasing investment in research collaborations.

The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to technological advancements in viral and non-viral vectors, expansion of personalized medicine and gene therapy applications, increasing regulatory approvals for innovative delivery systems, rising adoption of nanomedicine and LNPs, integration of digital monitoring and smart delivery platforms. Major trends in the forecast period include growth of targeted drug and gene therapies, rising adoption of nanoparticle-based delivery systems, increasing use of viral vectors for gene therapy, expansion of injectable and non-invasive delivery methods, focus on personalized medicine and controlled release technologies.

The increasing adoption of gene therapy is anticipated to support the expansion of the drug and gene delivery devices market going forward. Gene therapy involves modifying genetic material within a patient's cells to treat or prevent disease and is gaining attention due to its potential to address genetic and chronic conditions at their underlying causes. The growing adoption of gene therapy has increased demand for advanced delivery systems capable of precise targeting and controlled release of therapeutic genes. Drug and gene delivery devices play a critical role in enhancing treatment effectiveness and safety. For example, in January 2025, according to the American Society of Gene & Cell Therapy, a US-based non-profit organization, the number of pre-registration gene therapy programs in Q4 2024 increased by 83% compared to Q3 2024. As a result, the expanding adoption of gene therapy is reinforcing growth across the drug and gene delivery devices market.

Leading companies operating in the drug and gene delivery devices market are focusing on developing advanced solutions, such as artificial intelligence (AI)-enabled technologies, to enhance market competitiveness. AI technology in drug delivery involves the application of advanced algorithms and data-driven models to improve delivery precision, efficiency, and therapeutic effectiveness. For example, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles, launched an innovative gene therapy delivery platform that combines biopolymer nanoparticles with AI. This platform is designed to address limitations of existing gene delivery methods, including safety concerns, restricted payload capacity, and limited tissue targeting associated with viral vectors and lipid nanoparticles.

In January 2025, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical company, acquired Poseida Therapeutics Inc. for $1.5 billion. Through this acquisition, Roche aims to strengthen its oncology pipeline and expand its capabilities in allogeneic CAR-T cell therapies targeting blood cancers, solid tumors, and autoimmune diseases. Poseida Therapeutics Inc. is a US-based company specializing in complex immune cell therapies, including genetically modified CAR-T therapies for cancer and autoimmune disorders.

Major companies operating in the drug and gene delivery devices market are Medtronic plc, Moderna Inc., Halozyme Therapeutics Inc., Uniqure NV, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation, ICU Medical, Stevanato Group, Gerresheimer AG, Ypsomed, SHL Medical

North America was the largest region in the drug and gene delivery devices market in 2025. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug and gene delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug and gene delivery devices market consists of sales of microspheres and microneedles, electroporation devices, bio adhesive systems, and gene therapy vectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug And Gene Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug and gene delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug and gene delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug and gene delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vector: Viral; Non-viral
• 2) By Method: In Situ; Ex Vivo
• 3) By Route Of Administration: Oral; Inhalation; Transdermal; Injectable; Ocular; Nasal; Topical
• Subsegments:
• 1) By Viral: Adenovirus Vectors; Lentivirus Vectors; Adeno-Associated Virus (AAV) Vectors; Herpes Simplex Virus (HSV) Vectors; Retrovirus Vectors; Baculovirus Vectors; Vaccinia Virus Vectors; Sendai Virus Vectors
• 2) By Non-Viral: Lipid Nanoparticles (LNP); Polymeric Nanoparticles; Liposomes; Dendrimers; Naked DNA/RNA Delivery; Electroporation-Based Delivery Systems; Nanoparticle-Based Delivery Systems; Polymer Micelles And Hydrogels.
• Companies Mentioned: Medtronic plc; Moderna Inc.; Halozyme Therapeutics Inc.; Uniqure NV; Intellia Therapeutics Inc.; Voyager Therapeutics Inc.; sfm medical devices GmbH; Inovio Pharmaceuticals Inc.; GenSight Biologics S.A.; CRISPR Therapeutics; Pfizer Inc.; Novartis AG; Becton Dickinson and Company; Shanghai Sunway Biotech Co Ltd; Epeius Biotechnologies Corporation; SiBiono GeneTech Co Ltd; F Hoffmann-La Roche Ltd; Baxter International; B Braun Melsungen; Terumo Corporation; ICU Medical; Stevanato Group; Gerresheimer AG; Ypsomed; SHL Medical
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Drug And Gene Delivery Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Drug And Gene Delivery Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Drug And Gene Delivery Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Drug And Gene Delivery Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Growth Of Targeted Drug And Gene Therapies
  • 4.2.2 Rising Adoption Of Nanoparticle-Based Delivery Systems
  • 4.2.3 Increasing Use Of Viral Vectors For Gene Therapy
  • 4.2.4 Expansion Of Injectable And Non-Invasive Delivery Methods
  • 4.2.5 Focus On Personalized Medicine And Controlled Release Technologies

5. Drug And Gene Delivery Devices Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Hospitals And Clinics
• 5.4 Research Laboratories
• 5.5 Contract Research And Manufacturing Organizations (Cramos)

6. Drug And Gene Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug And Gene Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Drug And Gene Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Drug And Gene Delivery Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Drug And Gene Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Drug And Gene Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug And Gene Delivery Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug And Gene Delivery Devices Market Segmentation

• 9.1. Global Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral, Non-viral
• 9.2. Global Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• In Situ, Ex Vivo
• 9.3. Global Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
• 9.4. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
• 9.5. Global Drug And Gene Delivery Devices Market, Sub-Segmentation Of Non-Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels

10. Drug And Gene Delivery Devices Market Regional And Country Analysis

• 10.1. Global Drug And Gene Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Drug And Gene Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug And Gene Delivery Devices Market

• 11.1. Asia-Pacific Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug And Gene Delivery Devices Market

• 12.1. China Drug And Gene Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug And Gene Delivery Devices Market

• 13.1. India Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug And Gene Delivery Devices Market

• 14.1. Japan Drug And Gene Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug And Gene Delivery Devices Market

• 15.1. Australia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug And Gene Delivery Devices Market

• 16.1. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug And Gene Delivery Devices Market

• 17.1. South Korea Drug And Gene Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug And Gene Delivery Devices Market

• 18.1. Taiwan Drug And Gene Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug And Gene Delivery Devices Market

• 19.1. South East Asia Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug And Gene Delivery Devices Market

• 20.1. Western Europe Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug And Gene Delivery Devices Market

• 21.1. UK Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug And Gene Delivery Devices Market

• 22.1. Germany Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug And Gene Delivery Devices Market

• 23.1. France Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug And Gene Delivery Devices Market

• 24.1. Italy Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug And Gene Delivery Devices Market

• 25.1. Spain Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug And Gene Delivery Devices Market

• 26.1. Eastern Europe Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug And Gene Delivery Devices Market

• 27.1. Russia Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug And Gene Delivery Devices Market

• 28.1. North America Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug And Gene Delivery Devices Market

• 29.1. USA Drug And Gene Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug And Gene Delivery Devices Market

• 30.1. Canada Drug And Gene Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug And Gene Delivery Devices Market

• 31.1. South America Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug And Gene Delivery Devices Market

• 32.1. Brazil Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug And Gene Delivery Devices Market

• 33.1. Middle East Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug And Gene Delivery Devices Market

• 34.1. Africa Drug And Gene Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Drug And Gene Delivery Devices Market, Segmentation By Vector, Segmentation By Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug And Gene Delivery Devices Market Regulatory and Investment Landscape

36. Drug And Gene Delivery Devices Market Competitive Landscape And Company Profiles

• 36.1. Drug And Gene Delivery Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Drug And Gene Delivery Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Drug And Gene Delivery Devices Market Company Profiles
  • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Halozyme Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Uniqure NV Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Intellia Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Drug And Gene Delivery Devices Market Other Major And Innovative Companies

• Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics, Pfizer Inc., Novartis AG, Becton Dickinson and Company, Shanghai Sunway Biotech Co Ltd, Epeius Biotechnologies Corporation, SiBiono GeneTech Co Ltd, F Hoffmann-La Roche Ltd, Baxter International, B Braun Melsungen, Terumo Corporation

38. Global Drug And Gene Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug And Gene Delivery Devices Market

40. Drug And Gene Delivery Devices Market High Potential Countries, Segments and Strategies

• 40.1 Drug And Gene Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Drug And Gene Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Drug And Gene Delivery Devices Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer